Drug Profile
Domitroban
Alternative Names: Anboxan; S 1452Latest Information Update: 29 May 2001
Price :
$50
*
At a glance
- Originator Shionogi
- Class Antiallergics
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Arterial thrombosis; Asthma; Coronary thrombosis; Intracranial thrombosis
Most Recent Events
- 29 May 2001 Discontinued-II for Allergic rhinitis in Japan (PO)
- 29 May 2001 Discontinued-preregistration for Asthma in Japan (PO)
- 30 Jun 1998 Discontinued-Unspecified phase in Arterial thrombosis in Japan (PO)